Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Oncology (Williston Park, N.Y.)|May 19, 2016
Targeting PARP in Prostate Cancer: Novelty, Pitfalls, and PromisePhillip L Palmbos, Maha H HussainOncology (Williston Park, N.Y.)|July 2, 2011
Evolving therapeutic paradigms for advanced prostate cancerJoshua M Ruch, Maha H HussainCurrent Opinion in Oncology|March 21, 2013
Emerging therapies in metastatic castration-sensitive and castration-resistant prostate cancerGary R MacVicar, Maha H HussainExpert Review of Anticancer Therapy|July 13, 2002
Hormonal therapy for prostate cancer: past, present and futureBasil F el-Rayes, Maha H HussainAcademic Radiology|November 30, 2025
Yttrium-90 Radioembolization for Androgen-Independent Prostate Cancer Metastasis to the LiverMohamad M Alzein, Andrew C Gordon, Maha H Hussain, et al.Clinical Genitourinary Cancer|May 27, 2008
Phase II open-label study of oral piritrexim in patients with advanced carcinoma of the urothelium who have experienced failure with standard chemotherapyLance K Lassiter, Mohan K Tummala, Maha H Hussain, et al.Clinical & Experimental Metastasis|December 18, 2012
Integrin alpha2beta 1 (α2β1) promotes prostate cancer skeletal metastasisJoseph L Sottnik, Stephanie Daignault-Newton, Xiaotun Zhang, et al.Cancer|June 17, 2006
A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007Francis P Worden, James Moon, Wolfram Samlowski, et al.Cancer|June 20, 2007
Activity of second-line chemotherapy in docetaxel-refractory hormone-refractory prostate cancer patients : randomized phase 2 study of ixabepilone or mitoxantrone and prednisoneJonathan E Rosenberg, Vivian K Weinberg, W Kevin Kelly, et al.The Journal of Urology|April 12, 2005
A prospective analysis of the time to normalization of serum androgens following 6 months of androgen deprivation therapy in patients on a randomized phase III clinical trial using limited hormonal therapyJames L Gulley, William D Figg, Seth M Steinberg, et al.Pageof 3